News and Trends 8 Mar 2023 How to get started in life sciences – tips from six top women biotech leaders The life sciences industry might seem like an attractive sector for women to start their career and find a job. But just how should women get started in the sector? We asked six top professionals in the field for their advice. We asked Charli Batley, COO, Phoremost; Tamsin Mansley, president, Optibrium Inc. and global head […] March 8, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 Mar 2023 Women in STEM: challenges and opportunities In this article to celebrate International Women’s Day, we asked women in STEM for their comments on the challenges they have faced in their careers so far, and how solutions can emerge from these challenges. We get advice from Fiona McLaughlin, CSO, Avacta Therapeutics; Maureen Coleman, chairman, CN Bio; Debora Lucarelli, CEO, Enhanc3D Genomics; Tamsin […] March 8, 2023 - 14 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 Mar 2023 How to encourage more women in life science jobs In this article to celebrate International Women’s Day, we asked six women biotech professionals for their observations on women in the life sciences industry. We spoke to Sheelagh Frame, CSO, Ubiquigent; Debora Lucarelli, CEO, Enhanc3D Genomics; Charli Batley, COO, Phoremost; Tamsin Mansley, president, Optibrium Inc. and global head of application science, Optibrium; Maureen Coleman, chairman, […] March 8, 2023 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2023 Ubiquigent and University of Glasgow to collaborate on drug discovery Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, is supporting a Master’s student at the University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neruodegenerative, renal, and cardiovascular diseases. Overseen by structural biology experts […] January 24, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 We DUB this target ‘druggable’ By Sheelagh Frame, CSO at Ubiquigent Modulation of the ubiquitin-proteasome system (UPS) presents a rich source for drug discovery. Recent years have seen the clinical validation of proteolysis-targeting chimeras (PROTACs) unlock the ability to drug the undruggable, by exploiting E3 ligases to mediate targeted protein degradation (TPD), paving the way to tackle exciting new drug […] January 11, 2023 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
More News! 31 Oct 2022 Drug discovery company signs exclusive license to use university’s technology A drug discovery and development company using deubiquitylase (DUB) modulators as therapeutics for areas of high unmet needs has signed an exclusive license with the University of Southern Denmark for its UbiSite technology. Sheelagh Frame, is chief scientific officer, at Ubiquigent, the company that has signed the agreement. She said: “We are delighted to have […] October 31, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email